Recent
- Molecular markers for biological dosimetry in radiation oncology. Cancer risk assessment and cancer treatment optimization. Applications of biological dosimetry methods in radiation oncology, nuclear medicine, diagnostic and interventional radiology, International Atomic Energy Agency, IAEA RA No.: 22259/R0, 14.07.2017-09.07.2023, principal investigator Igor Belyaev, DrSc.
- MVTS from SAV budget funds: Molecular markers for biological dosimetry in radiation oncology, cancer risk assessment and optimization of cancer treatment. Parent project: Applications of Biological Dosimetry Methods in Radiation Oncology, Nuclear Medicine, and Diagnostic and Interventional Radiology (MEDBIODOSE) – IAEA Research Contract No: 24714. 10.07.2017 – 9.7.2023, principal investigator Igor Belyaev, DrSc.
- Structural Funds of the European Union: Long-term strategic research on prevention, intervention and mechanisms of obesity and its comorbidities. NFP313010V344, 09-2019 – 06-2023 (Operational program Integrated infrastructure for the project: Long-term strategic research on prevention, intervention and mechanisms of obesity and its comorbidities, IMTS: 313011V344, co-financed by the European Regional Development Fund). PI: prof. Silvia Pastoreková, DrSc. responsible investigator of sub-activity 2.4. Igor Belyajev, DrSc.